NOVARTIS AG (NVSEF)
Clinical trial NCT05147220 updates: 1. primary completion date: 2026-04-30 → 2026-07-23 2. enrollment: not set → 1000 participants
Clinical trial NCT05147220 updates: 1. primary completion date: 2026-04-30 → 2026-07-23 2. enrollment: not set → 1000 participants
Clinical trial NCT07325292: enrollment: not set → 160 participants.
Clinical trial NCT06153667: enrollment: not set → 100 participants.
Clinical trial NCT07492680: enrollment: not set → 260 participants.
Clinical trial NCT07184931: enrollment: not set → 980 participants.
Clinical trial NCT06052631 updates: 1. start date: 2026-06-02 → 2026-06-03 2. enrollment: not set → 16 participants
Clinical trial NCT07544589: enrollment: not set → 66 participants.
Clinical trial NCT07611708: enrollment: not set → 25 participants.
Clinical trial NCT07114601: enrollment: not set → 421 participants.
Clinical trial NCT05718323: enrollment: not set → 44 participants.